-+ 0.00%
-+ 0.00%
-+ 0.00%
Oculis to Present Licaminlimab at Eyecelerator @ AAO 2026
Share
Listen to the news
Oculis to Present Licaminlimab at Eyecelerator @ AAO 2026
  • Oculis will present its dry-eye drug candidate Licaminlimab at Eyecelerator @ AAO 2026 on Oct. 8 in New Orleans.
  • CEO Riad Sherif is scheduled to speak in the anterior segment showcase session at 1:24 p.m. CDT.
  • The company will sponsor AAO 2026’s Neuro-Ophthalmology Subspecialty Day on Oct. 9.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oculis Holding AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610070159PRIMZONEFULLFEED1001276672) on October 07, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending